ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment

March 5, 1999

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995